These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26169942)

  • 1. Elevated mutant dynorphin A causes Purkinje cell loss and motor dysfunction in spinocerebellar ataxia type 23.
    Smeets CJ; Jezierska J; Watanabe H; Duarri A; Fokkens MR; Meijer M; Zhou Q; Yakovleva T; Boddeke E; den Dunnen W; van Deursen J; Bakalkin G; Kampinga HH; van de Sluis B; Verbeek DS
    Brain; 2015 Sep; 138(Pt 9):2537-52. PubMed ID: 26169942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebellar developmental deficits underlie neurodegenerative disorder spinocerebellar ataxia type 23.
    Smeets CJLM; Ma KY; Fisher SE; Verbeek DS
    Brain Pathol; 2021 Mar; 31(2):239-252. PubMed ID: 33043513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23.
    Bakalkin G; Watanabe H; Jezierska J; Depoorter C; Verschuuren-Bemelmans C; Bazov I; Artemenko KA; Yakovleva T; Dooijes D; Van de Warrenburg BP; Zubarev RA; Kremer B; Knapp PE; Hauser KF; Wijmenga C; Nyberg F; Sinke RJ; Verbeek DS
    Am J Hum Genet; 2010 Nov; 87(5):593-603. PubMed ID: 21035104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered secondary structure of Dynorphin A associates with loss of opioid signalling and NMDA-mediated excitotoxicity in SCA23.
    Smeets CJ; Zmorzyńska J; Melo MN; Stargardt A; Dooley C; Bakalkin G; McLaughlin J; Sinke RJ; Marrink SJ; Reits E; Verbeek DS
    Hum Mol Genet; 2016 Jul; 25(13):2728-2737. PubMed ID: 27260403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
    Cummings CJ; Orr HT; Zoghbi HY
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice.
    Shuvaev AN; Hosoi N; Sato Y; Yanagihara D; Hirai H
    J Physiol; 2017 Jan; 595(1):141-164. PubMed ID: 27440721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased protein kinase C gamma activity induces Purkinje cell pathology in a mouse model of spinocerebellar ataxia 14.
    Ji J; Hassler ML; Shimobayashi E; Paka N; Streit R; Kapfhammer JP
    Neurobiol Dis; 2014 Oct; 70():1-11. PubMed ID: 24937631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of metabotropic glutamate receptor signalling is a major defect at cerebellar parallel fibre-Purkinje cell synapses in staggerer mutant mice.
    Mitsumura K; Hosoi N; Furuya N; Hirai H
    J Physiol; 2011 Jul; 589(Pt 13):3191-209. PubMed ID: 21558162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient cerebellar alterations during development prior to obvious motor phenotype in a mouse model of spinocerebellar ataxia type 6.
    Jayabal S; Ljungberg L; Watt AJ
    J Physiol; 2017 Feb; 595(3):949-966. PubMed ID: 27531396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations.
    Clark HB; Burright EN; Yunis WS; Larson S; Wilcox C; Hartman B; Matilla A; Zoghbi HY; Orr HT
    J Neurosci; 1997 Oct; 17(19):7385-95. PubMed ID: 9295384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-opioid nociceptive activity of human dynorphin mutants that cause neurodegenerative disorder spinocerebellar ataxia type 23.
    Watanabe H; Mizoguchi H; Verbeek DS; Kuzmin A; Nyberg F; Krishtal O; Sakurada S; Bakalkin G
    Peptides; 2012 Jun; 35(2):306-10. PubMed ID: 22531488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1.
    Notartomaso S; Zappulla C; Biagioni F; Cannella M; Bucci D; Mascio G; Scarselli P; Fazio F; Weisz F; Lionetto L; Simmaco M; Gradini R; Battaglia G; Signore M; Puliti A; Nicoletti F
    Mol Brain; 2013 Nov; 6():48. PubMed ID: 24252411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular FGF14 (iFGF14) Is Required for Spontaneous and Evoked Firing in Cerebellar Purkinje Neurons and for Motor Coordination and Balance.
    Bosch MK; Carrasquillo Y; Ransdell JL; Kanakamedala A; Ornitz DM; Nerbonne JM
    J Neurosci; 2015 Apr; 35(17):6752-69. PubMed ID: 25926453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant β-III spectrin causes mGluR1α mislocalization and functional deficits in a mouse model of spinocerebellar ataxia type 5.
    Armbrust KR; Wang X; Hathorn TJ; Cramer SW; Chen G; Zu T; Kangas T; Zink AN; Öz G; Ebner TJ; Ranum LP
    J Neurosci; 2014 Jul; 34(30):9891-904. PubMed ID: 25057192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-type plasminogen activator is an extracellular mediator of Purkinje cell damage and altered gait.
    Cops EJ; Sashindranath M; Daglas M; Short KM; da Fonseca Pereira C; Pang TY; Lijnen RH; Smyth IM; Hannan AJ; Samson AL; Medcalf RL
    Exp Neurol; 2013 Nov; 249():8-19. PubMed ID: 23939410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease.
    Nascimento-Ferreira I; Nóbrega C; Vasconcelos-Ferreira A; Onofre I; Albuquerque D; Aveleira C; Hirai H; Déglon N; Pereira de Almeida L
    Brain; 2013 Jul; 136(Pt 7):2173-88. PubMed ID: 23801739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of dynorphins in Alzheimer's disease and age-related cognitive deficits.
    Ménard C; Herzog H; Schwarzer C; Quirion R
    Neurodegener Dis; 2014; 13(2-3):82-5. PubMed ID: 23970097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.
    Corral-Juan M; Serrano-Munuera C; Rábano A; Cota-González D; Segarra-Roca A; Ispierto L; Cano-Orgaz AT; Adarmes AD; Méndez-Del-Barrio C; Jesús S; Mir P; Volpini V; Alvarez-Ramo R; Sánchez I; Matilla-Dueñas A
    Brain; 2018 Jul; 141(7):1981-1997. PubMed ID: 29939198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of beta-III spectrin leads to Purkinje cell dysfunction recapitulating the behavior and neuropathology of spinocerebellar ataxia type 5 in humans.
    Perkins EM; Clarkson YL; Sabatier N; Longhurst DM; Millward CP; Jack J; Toraiwa J; Watanabe M; Rothstein JD; Lyndon AR; Wyllie DJ; Dutia MB; Jackson M
    J Neurosci; 2010 Apr; 30(14):4857-67. PubMed ID: 20371805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced Purkinje cell size is compatible with near normal morphology and function of the cerebellar cortex in a mouse model of spinocerebellar ataxia.
    Trzesniewski J; Altmann S; Jäger L; Kapfhammer JP
    Exp Neurol; 2019 Jan; 311():205-212. PubMed ID: 30312605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.